NEW YORK – Archeus Technologies on Friday said the US Food and Drug Administration cleared its investigational new drug application (IND) for the theranostic radiopharmaceutical agent ART-101 in ...

For selected applicants, the agency plans to cut review times down to one to two months and provide "tumor board-style" ...

NEW YORK – Singapore's Ministry of Health announced this week it will launch a genetic testing program to improve diagnosis of familial hypercholesterolemia (FH) as part of a broader national focus on ...

In the growing rare disease precision medicine market, drug companies must avoid funding genetic testing that the Justice ...

The agency maintains that the beta-amyloid-targeting drugs show too limited benefit to justify their cost to the National Health Service.

NEW YORK – Researchers at the Cambridge University Hospital and The Royal Marsden Hospital in London have begun enrolling patients with malignant brain tumors into two genomically informed treatment ...

NEW YORK – BioNTech will lay off 63 employees and will discontinue cell therapy manufacturing at its plant in Gaithersburg, Maryland by the end of the year, the company said this week. These changes ...

The US subsidiary will focus on advancing PolTreg's pipeline in these new territories, including its lead candidate PTG-007 in type 1 diabetes.